Additional file 2 of EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Autor: Leichsenring, Jonas, Vladimirova, Valentina, Solbach, Christine, Karn, Thomas, Ataseven, Beyhan, Sinn, Bruno Valentin, Barinoff, Jana, Müller, Volkmar, Blohmer, Jens-Uwe, Schem, Christian, Engels, Knut, Marmé, Frederik, Fisseler-Eckhoff, Annette, Fasching, Peter A., Stickeler, Elmar, van Mackelenbergh, Marion, Denkert, Carsten, Stenzinger, Albrecht, Loibl, Sibylle, Gröschel, Stefan
Rok vydání: 2022
DOI: 10.6084/m9.figshare.21275636
Popis: Additional file 2: Supplementary Figure 2. Distribution of EVI1 continuous expression in breast cancer: A: Histogram of EVI1 continuous expression in the entire cohort (N=993); B: Boxplots of EVI1 continuous expression within breast cancer subtypes. Note, 882/993 patients with available BC subtype information were included in this analysis. Horizontal bold lines present EVI1 median values of 116.65 in HR+/HER2-, 98.67 in HR+/HER2+, 114.77in HR-/HER2+, and 115.64 in TNBC; boxes present the interquartile range between first quartile and third quartile of the dataset; whiskers present the range from the smallest and the highest number of the dataset). Abbreviations: HR, hormone receptor; HER2, human epidermal growth factor receptor 2; TNBC, triple-negative breast cancer.
Databáze: OpenAIRE